Multiple Sclerosis Trial, Recruiting NCT05433103 Sponsor: VA Office of Research and Development Condition: Multiple Sclerosis
Back to Multiple Sclerosis

Multiple Sclerosis Trial, Recruiting

NCT05433103
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have a confirmed diagnosis of multiple sclerosis (MS)
  • People between 18 and 75 years of age
  • People whose MS-related walking ability falls within a specific range — this means people who use a cane, crutch, walker, or support to walk some or all of the time, up to and including people whose main way of getting around is a wheelchair or scooter, as long as sitting in a wheelchair for more than one hour is still possible

Who may not be able to join:

  • People who are unable to sit in a wheelchair for more than one hour
  • People whose MS has little or no impact on walking — for example, those who can generally walk without a cane or other aid, even if some activities have become harder
  • People with moderate to severe problems with memory or thinking, as measured by a specific mental status test (confirm with trial site for exact scoring details)
  • People with a history of blood clots in the veins or lungs, poor circulation in the limbs, or conditions that affect blood clotting
  • People with very high blood pressure (systolic 180 mmHg or higher, or diastolic 110 mmHg or higher)
  • People with other health conditions or pain that significantly affect physical function or would make it unsafe to take part in a rehabilitation program, as assessed by a neurologist or physiotherapist
  • People who bruise easily
  • People with severe muscle stiffness in the lower limbs, as measured by a standard clinical scale (confirm with trial site for exact details)
  • People who are currently doing, or have done in the past two months, a structured progressive resistance (strength) training program
  • People who are currently using, or have used in the past two months, a blood flow restriction technique
  • People who have had an MS relapse or a change to their MS medication in the month before enrolling
  • People who are unable to tolerate a pressure cuff during the initial assessment
  • People who are unable to perform a seated leg press exercise, or who have no ability to lift their leg at the knee against gravity in either limb

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 26 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Mark M Manago, PT, Rocky Mountain Regional VA Medical Center, Aurora, CO

Phone: (303) 399-8020

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
1 January 2023
Est. completion
31 December 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Quadriceps muscle strength

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov